Natural killer/T-cell lymphomas are extremely rare and carry high mortality rates. Epidemiologically, these cancers tend to affect mainly Asian and South American patients and are associated with Epstein-Barr virus seropositivity. This report details a 78-year-old Vietnamese woman who presented initially with vitritis of unknown cause, but later developed proptosis and conjunctival involvement as her disease spread. Biopsies of the orbit, ethmoid sinus, and conjunctiva were found to be significant for natural killer/T-cell lymphoma. The case highlights the diagnostic difficulty of this tumor given its rarity and ability to mimic other disorders.
M ost lymphomas involving the orbit and globe are nonHodgkin's B-cell lymphomas (1) . Only about 2% of intraocular lymphomas are non-B-cell tumors, and those expressing natural killer (NK) cell markers are typically highly aggressive and carry a poor prognosis (2). Since they arise primarily from the nasal mucosa, NK/T-cell lymphomas have the ability to invade the orbit and globe (2) . Herein we present a case of NK/T-cell lymphoma in a 78-year-old Vietnamese woman who initially presented with vision problems and was successfully treated with chemotherapy.
CASE REPORT
A 78-year-old Vietnamese woman with a past medical history of coronary artery disease, hyperlipidemia, and hypothyroidism presented with a 6-month history of blurred vision in the left eye associated with sporadic pressure-like pain in that eye. On exam, vision in the left eye was 20/50, and there was no improvement with pinhole testing. Her intraocular pressure in the left eye was 10 mm Hg. Th e patient demonstrated mild vitritis and periphlebitis with vascular sheathing in the temporal periphery on the left. She also manifested a pigmented chorioretinal scar in the superonasal periphery of the same eye. Th e remainder of the exam, including pupils and extraocular movements, was normal.
Th e patient was initially diagnosed with uveitis and treated with a dexamethasone intravitreal implant; however, she developed recurrence of symptoms after implant dissolution. Serologic workup was performed that included tests for antineutrophil cytoplasmic antibody, toxoplasma IgM and IgG, rapid plasma reagin, QuantiFERON tuberculosis, and Lyme antibodies, all of which were negative. Th e patient also demonstrated a normal erythrocyte sedimentation rate, C-reactive protein level, and angiotensin-converting enzyme level. Magnetic resonance imaging with contrast demonstrated a metallic foreign body in the preseptal upper lid but was otherwise unremarkable and notably negative for any mass lesions, including central nervous system lymphoma, and an anterior chamber paracentesis failed to yield diagnostic results.
Two months later, the patient returned with an infl amed salmon-colored lesion within the medial conjunctiva of the left eye and markedly decreased visual acuity on the left to 20/200. Examination demonstrated supra-, infra-, and abduction defi cits on the left with mechanical ptosis, as well as 5 mm of proptosis and mild resistance to retropulsion.
Due to the presence of a metallic foreign body, a contrastenhanced computed tomography (CT) scan of the head was substituted for magnetic resonance imaging. Th is scan demonstrated extensive opacifi cation of the left maxillary and ethmoid sinuses, as well as an invasive pattern of hyperdense material fi lling the majority of the left intraconal space, which extended anteriorly, causing protrusion of the subcutaneous tissue of the inferior eyelid (Figure 1) .
Th e patient underwent orbitotomy with biopsy of the abnormal tissue in the left orbit and ethmoid sinus as well as a conjunctival biopsy. Pathology results revealed intermediate-to large-sized neoplastic CD2 + , CD56 + , CD5 + lymphoid cells, highlighting an atypical prominent population of true NK cells (Figure 2) . In situ hybridization for Epstein-Barr virus was strongly and diff usely positive in neoplastic cells. Th e diagnosis of extranodal NK/T-cell lymphoma nasal type was made, and the patient underwent tumor staging. A positron emission tomography (PET) scan demonstrated extensive metabolically active disease, indicating a stage IVA diagnosis. Th e patient received three of six planned cycles of gemcitabine, oxaliplatin,
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Th e prognosis of extranodal NK/T-cell lymphomas is worse than that of their B-cell counterparts (12) . While early stage, localized disease is highly curable, metastatic disease and refractory cases carry a 5-year survival rate of <10% (13). Treatment for localized disease (stage I/II) includes chemotherapy and radiotherapy; however, disseminated disease is treated with and L-asparaginase (GELOX) chemotherapy. Her therapy was suspended due to severe treatment-induced debilitation; however, she remains in complete remission by both CT and PET scan as of her most recent follow-up 10 months following her initial oncologic consultation.
DISCUSSION
NK/T-cell lymphoma is a rare and aggressive subtype most common in Asian and South American populations and associated with EBV (3). While most ocular and orbital lymphomas are of the non-Hodgkin's B-cell variety, the nasal type combination chemotherapy (14) . Furthermore, expression of P-glycoprotein (an active drug-export mechanism) on NK/Tcell lymphoma cells confers multidrug resistance (15) , so regimens such as cyclophosphamide, doxorubicin, vincristine, and prednisolone have largely been replaced with methotrexate-and ifosfamide-containing regimens (16) . L-asparaginase is another crucial component of the chemotherapeutic regimen, and phase II studies of dexamethasone, methotrexate, ifosfamide, etoposide, and L-asparaginase (SMILE) therapy have shown 1-year overall survival and progression-free survival rates of 45% and 45%, respectively (17) . Th is patient was treated with GELOX, which in one prospective study showed a 2-year overall survival rate of 86% and a progression-free survival rate of 86%, with a local relapse rate of 15% and systemic relapse rate of 11% (18) . It is important to consider the diagnosis of NK/T-cell lymphoma in patients complaining of orbital swelling, especially those with concomitant fi ndings of ocular infl ammation or other systemic complaints. Orbital biopsy should be considered in cases of chronic uveitis with nondiagnostic vitreous biopsy and orbital imaging fi ndings. When diagnosed early, treatment with radio-and chemotherapy can be eff ective for regional sinoorbital NK/T-cell lymphoma.
